文献速递病毒性肝炎

无干扰素直接抗病毒治疗清除丙肝病毒后诱导KLRG1+丙肝特异性记忆NK细胞

Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells.
PubMed 文献 · J Infect Dis · 2021-01-01

该研究比较健康对照与慢性丙肝患者治疗前后(SVR12)的NK细胞表型和应答,发现SVR12时成熟标志物CD16、CD57和KLRG1增加;丙肝患者对HCV感染细胞的杀伤反应强于健康对照且SVR12后进一步增强,该抗原特异性反应由KLRG1+ NK细胞介导。

要点

  • 慢性HCV感染经DAA治疗达SVR12后NK细胞成熟标志物CD16、CD57、KLRG1升高
  • HCV患者NK细胞对HCV感染细胞的杀伤反应强于健康对照,SVR12后进一步增强
  • 抗原特异性脱颗粒和增殖反应仅见于KLRG1+ NK细胞

核心结论

  • HCV感染后可诱导产生KLRG1+ HCV特异性记忆NK细胞,可能参与病毒清除并与疫苗设计相关。

研究设计与样本

  • 比较健康对照与慢性HCV患者治疗前及SVR12后的NK细胞表型和应答。

主要发现

  • SVR12时NK细胞表型与配对治疗前样本显著不同,CD16、CD57和KLRG1增加。
  • HCV患者对HCV感染细胞的杀伤反应强于健康对照,SVR12后进一步增强。
  • 抗原特异性反应表现为仅对HCV抗原的脱颗粒和增殖增加,由KLRG1+ NK细胞介导。

临床怎么用

  • DAA清除HCV后NK细胞成熟表型及HCV特异性记忆样应答增强,提示治疗可恢复并塑造NK细胞免疫记忆。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Direct acting antiviral therapies rapidly clear chronic hepatitis C virus (HCV) infection and restore natural killer (NK) cell function. We investigated NK-cell memory formation following HCV clearance by examining NK-cell phenotype and responses from control and chronic HCV patients before and after therapy following sustained virologic response at 12 weeks post therapy (SVR12). NK-cell phenotype at SVR12 differed significantly from paired pretreatment samples, with an increase in maturation markers CD16, CD57, and KLRG1. HCV patients possessed stronger cytotoxic responses against HCV-infected cells as compared to healthy controls; a response that further increased following SVR12. The antigen-specific response was mediated by KLRG1+ NK cells, as demonstrated by increased degranulation and proliferation in response to HCV antigen only. Our data suggest that KLRG1+ HCV-specific memory NK cells develop following viral infection, providing insight into their role in HCV clearance and relevance with regard to vaccine design.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wijaya RS, Read SA, Selvamani SP, et al. Hepatitis C Virus (HCV) Eradication With Interferon-Free Direct-Acting Antiviral-Based Therapy Results in KLRG1+ HCV-Specific Memory Natural Killer Cells. J Infect Dis. 2021. PMID: 32777077. doi:10.1093/infdis/jiaa492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。